검색어 : 통합검색[950]
총 50,212건 중 1,000건 출력
, 96/100 페이지
-
951
- Identification of a Structurally Distinct CD101 Molecule Encoded in the 950-kb<i>Idd10</i>Region of NOD Mice
- Penha-Gonç alves, Carlos; Moule, Carolyn; Smink, Luc J.; Howson, Joanna; Gregory, Simon; Rogers, Jane; Lyons, Paul A.; Suttie, Joseph J.; Lord, Christopher J.; Peterson, Laurence B.; Todd, John A.; Wicker, Linda S.; Juvenile Diabetes Research Foundation/Wellcome Trust (JDRF/WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K; Juvenile Diabetes Research Foundation/Wellcome Trust (JDRF/WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K; Juvenile Diabetes Research Foundation/Wellcome Trust (JDRF/WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K; Juvenile Diabetes Research Foundation/Wellcome Trust (JDRF/WT) Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, U.K; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Camp; (Diabetes, v.52, 2003, pp.1551-1556)
-
952
- SiC/SiO<SUB>2</SUB> Structure Formed at ∼ 200°C by Heat Treatment at 950°C Having Excellent Electrical Characteristics
- Sakurai, Takeaki; Park, Jong Wook; Nishioka, Yasushiro; Nishiyama, Masayoshi; Kobayashi, Hikaru; ; (Japanese journal of applied physics. Part 1, Regular papers, short notes and review papers, v.41, 2002, pp.2516-2518)
-
953
- Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease
- Perni, Robert B.; Almquist, Susan J.; Byrn, Randal A.; Chandorkar, Gurudatt; Chaturvedi, Pravin R.; Courtney, Lawrence F.; Decker, Caroline J.; Dinehart, Kirk; Gates, Cynthia A.; Harbeson, Scott L.; Heiser, Angela; Kalkeri, Gururaj; Kolaczkowski, Elaine; Lin, Kai; Luong, Yu-Ping; Rao, B. Govinda; Taylor, William P.; Thomson, John A.; Tung, Roger D.; Wei, Yunyi; Kwong, Ann D.; Lin, Chao; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139; Vertex Pharmaceutica; (Antimicrobial agents and chemotherapy, v.50, 2006, pp.899-909)
-
954
- David N. Dumville, English Caroline Script and Monastic History: Studies in Benedictinism, A.D. 950-1030
- Martin, G. H.; ; (The Library, v.suppl6, 1997, pp.363)
-
955
- 950. Biodistribution and Safety Profile of CERE-120 (AAV2-NTN) Delivered to the Rodent Brain
- Landers, M.; Kwok, K.; Ketchum, E.; Wilson, C.; Lin, R.; Gammon, D.; Austin, M.; Manlapaz, L.; Wilson, A.; Cunningham, J.; Vacante, D.; Gasmi, M.; Bishop, K.; Printz, M.; Bartus, R.; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; R&D, Ceregene Inc, San Diego, CA; (Molecular therapy : the journal of the American Society of Gene Therapy, v.11, 2005, pp.367-367)
-
956
- ChemInform Abstract: OXIDATION OF ION‐IMPLANTED TITANIUM IN THE 750‐950° TEMPERATURE RANGE
- PONS, M.; CAILLET, M.; GALERIE, A.; ; (Chemischer Informationsdienst, v.16, 1985, pp.chin.198547028)
-
957
- 950 Maternal and neonatal outcomes of implementation of a computer-based software for intrapartum glucose management
- Berwick, Margarita; Silva, Lauren; Solly, Miranda; Palau, Xuban; Porritt, Kayleigh; Mestre, Cathleen; Wen, Tony S.; ; (American journal of obstetrics and gynecology, v.230, 2024, pp.S502)
-
958
- Hot corrosion behaviors of as-sprayed and laser-remelted YSZ thermal barrier coatings at 950 °C
- Yang, Z.G.; Liang, W.P.; Miao, Q.; Ding, Z.; Huang, B.Z.; Anyang Institute of Technology, China; Nanjing University of Aeronautics and Astronautics, China; Nanjing University of Aeronautics and Astronautics, China; Nanjing University of Aeronautics and Astronautics, China; Nanjing University of Aeronautics and Astronautics, China; Nanjing University of Aeronautics and Astronautics, China; (Matéria, v.27, 2022, pp.e20220052)
-
959
- Low Cycle Fatigue/Corrosion Interactions at 950 °C of AM1 Single Crystal Nickel-Based Superalloy
- Martin, A.; Drouelle, E.; Rame, J.; Cormier, J.; Pedraza, F.; ; (High temperature corrosion of materials, v.101, 2024, pp.961-970)
-
960
- Treatment of Acid Drainage with a Constructed Wetland at the Tennessee Valley Authority 950 Coal Mine
- Brodie, G. A.; Hammer, D. A.; Tomljanovich, D. A.; ; (Constructed wetlands for wastewater treatment, v.1989, 1989, pp.201-210)
QUICK MENU
